Signia Pure C&G BCT IX vs Sony CRE-C20

The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.

The Sony CRE-C20 is a mid-priced OTC hearing aid with an invisible-in-ear design, available for $999. In our lab testing, it earned a B grade with a SoundScore of 3.5/5, ranking #37 of 65 OTC hearing aids tested. This device shows a notable split in performance. Speech clarity is a clear strength—speech in quiet scores 4.1/5, which is 1.33 points above the category average, and speech in noise scores 2.7/5, sitting 1.24 points above average despite being only mixed in absolute terms. These results suggest the CRE-C20 prioritizes conversational intelligibility in its tuning approach. However, the device has significant limitations. Music streaming scored 0.0/5, falling 1.92 points below the category average—a notable weakness for users who want to stream audio. Feedback handling is solid at 3.9/5, though it sits 0.64 points below the category average of 4.54/5. Own voice comfort is mixed at 2.9/5, slightly above the category average. The CRE-C20 responds well to adjustment, with the normalized score improving from 3.3/5 at initial fit to 4.2/5 when tuned—a 0.9-point gain. Buyers focused primarily on speech understanding in conversations may find value here, but those wanting music streaming or seeking the strongest overall OTC performance should note that several competitors in this price range, including the Sony CRE-E10 at 4.66/5, scored higher in our testing.